Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome

J I Maiztegui; N J Fernandez; A J de Damilano

doi:10.1016/s0140-6736(79)92335-3

Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome

Lancet. 1979 Dec 8;2(8154):1216-7. doi: 10.1016/s0140-6736(79)92335-3.

Authors

J I Maiztegui, N J Fernandez, A J de Damilano

PMID: 92624
DOI: 10.1016/s0140-6736(79)92335-3

Abstract

In a double-blind trial patients with Argentine haemorrhagic fever treated with immune plasma within 8 days of the onset of the disease had a much lower mortality than those given normal plasma. Some patients treated with immune plasma developed late neurological complications.

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Blood Donors
Cerebellar Diseases / etiology
Clinical Trials as Topic
Double-Blind Method
Hemorrhagic Fever, American / mortality
Hemorrhagic Fever, American / therapy*
Humans
Immunization, Passive* / adverse effects
Neurologic Manifestations*
Retrospective Studies
Time Factors